India · Delayed Price · Currency is INR Amerise Biosciences Statistics
Total Valuation
BOM:531681 has a market cap or net worth of INR 46.91 million. The enterprise value is 40.99 million.
| Market Cap | 46.91M |
| Enterprise Value | 40.99M |
Important Dates
The last earnings date was Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:531681 has 66.07 million shares outstanding. The number of shares has decreased by -7.22% in one year.
| Current Share Class | 66.07M |
| Shares Outstanding | 66.07M |
| Shares Change (YoY) | -7.22% |
| Shares Change (QoQ) | +187.79% |
| Owned by Insiders (%) | 4.48% |
| Owned by Institutions (%) | 7.22% |
| Float | 46.93M |
Valuation Ratios
The trailing PE ratio is 270.37.
| PE Ratio | 270.37 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 254.60 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | 198.98 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.30
| Current Ratio | 0.30 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.30% and return on invested capital (ROIC) is 0.32%.
| Return on Equity (ROE) | 0.30% |
| Return on Assets (ROA) | 0.16% |
| Return on Invested Capital (ROIC) | 0.32% |
| Return on Capital Employed (ROCE) | 0.38% |
| Weighted Average Cost of Capital (WACC) | 5.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:531681 has paid 45,000 in taxes.
| Income Tax | 45,000 |
| Effective Tax Rate | 21.84% |
Stock Price Statistics
The stock price has decreased by -13.41% in the last 52 weeks. The beta is 0.23, so BOM:531681's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -13.41% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 49.08 |
| Average Volume (20 Days) | 63,121 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | 206,000 |
| Pretax Income | 206,000 |
| Net Income | 161,000 |
| EBITDA | n/a |
| EBIT | 206,000 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 5.92 million in cash and n/a in debt, with a net cash position of 5.92 million or 0.09 per share.
| Cash & Cash Equivalents | 5.92M |
| Total Debt | n/a |
| Net Cash | 5.92M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 53.96M |
| Book Value Per Share | 0.88 |
| Working Capital | -14.14M |
Cash Flow
| Operating Cash Flow | -10.57M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:531681 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.22% |
| Shareholder Yield | 7.22% |
| Earnings Yield | 0.34% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |